Events Search and Views Navigation
November 2014
Better Science, Better Health: Mark Trusheim of MIT Outlines the Economic Impact of MAPPs
A gathering of the world’s thought leaders in medicine’s adaptive pathways to patients (MAPPs). Mark Trusheim from NEWDIGS and the MIT Sloan School of Management outlines his recent research on MAPPs for improved patient access and the ROI for industry with various scenarios considered.
Find out more »January 2015
NEWDIGS 2015 Data Program Workshop
Review and discuss plan for and status update on the NEWDIGS Data Program.Click here for full event details. For attendees*: Agenda and presentations page
Find out more »February 2015
Interdisciplinary Center for Bioethics, Institution of Social and Policy Studies
Presentation: Adaptive Risk Management in Biotechnology: Applications to Transfats, Synthetic Biology and Pharmaceuticals.Ken Oye (MIT).
Find out more »MIT Media Lab
Co-sponsored by MIT Media Lab, Deloitte, & Decision Resources Group. The Future of Health Analytics. Panel Discussion on Emerging Trends, Technologies, & Opportunities, featuring Gigi Hirsch, MIT Center for BioMedical Innovation and Executive Director NEWDIGS, on the NEWDIGS Data Program.
Find out more »March 2015
April 2015
DIA Europe 27th Annual EuroMeeting
Panel Discussion on Adaptive Licensing. James Anderson (GSK), Susanna Del-Signore (Sanofi), Hans-Georg Eichler (EMA), Gigi Hirsch (MIT)Full program here.
Find out more »Webinar: MAPPs – New Tools for Decision making
What is the current status of MAPPs in Europe and the US? FeaturingLuca Pani, Director General, Italian Medicines Agency Gigi Hirsch, Executive Director, CBI and Program Director, NEWDIGS, MIT, USA James Anderson, Head of Corporate Government Affairs, GlaxoSmithKline, UK Duane Schulthess, Managing Director, Vital Transformation (moderator) More information here.
Find out more »May 2015
ISPOR 20th Annual International Meeting
Panel: Early Access to Medicines: What’s in it for Payers? Panelists: Adam Heathfield (Pfizer), Mark Trusheim (MIT); Dan Ollendorf (ICER), Adrian Towse (Office of Health Economics, London).More information here.
Find out more »July 2015
MIT NEWDIGS Janus Program Workshop: Payer/HTA Adaptive Pathways
Participants in this workshop will include a broad range of representatives from the global biopharmaceutical/healthcare industry including manufacturers, regulatory agencies, public and private payers and HTA officials, and academia, among others. Outputs from the workshop will be summarized and made available to all attendees.Objectives Elucidate the reimbursement challenges of “Adaptive Pathways” (occasionally referred to as MAPPs or adaptive licensing”) for payers/HTAs and sponsors. Refine a strategic framework for the ‘right side’ of the “Adaptive Pathways” roadmap: Creative coverage and reimbursement…
Find out more »National Science Advisory Board on Biosecurity, Working Group
Presentation: Risk Management under Uncertainty, Complexity and Controversy: Proactive and Adaptive Strategies.Ken Oye (MIT).
Find out more »